首页 | 本学科首页   官方微博 | 高级检索  
检索        

血管紧张素转换酶抑制剂治疗阿尔茨海默病的效果
引用本文:储佺兵,苑瑞敏,童玉翠,陈广生,许家佳,张晗,孙永安.血管紧张素转换酶抑制剂治疗阿尔茨海默病的效果[J].江苏医药,2012,38(15):1800-1802.
作者姓名:储佺兵  苑瑞敏  童玉翠  陈广生  许家佳  张晗  孙永安
作者单位:1. 马鞍山十七冶医院神经内科,安徽省,243000
2. 北京大学第一医院神经内科
摘    要:目的观察血管紧张素转换酶抑制剂(ACEI)治疗阿尔茨海默病(AD)痴呆患者的精神行为症状、认知功能损害的效果。方法 52例AD痴呆患者口服盐酸卡托普利治疗12周,采用神经精神科问卷(NPI)评定患者的精神行为症状变化,采用简易智能状态检查量表评定患者的认知功能变化。结果治疗12周后,除情感淡漠外,NPI各项因子得分显著下降(P<0.05),NPI总分下降81.47%(P<0.05);照顾者的苦恼程度也随着患者精神行为症状的改善而降低;治疗前后患者的认知功能无显著性差异(P>0.05)。结论盐酸卡托普利可以明显改善AD痴呆患者的精神行为症状,但对患者的认知功能损害无明显疗效。

关 键 词:阿尔茨海默病  血管紧张素转换酶抑制剂

Effects of angiotensin converting enzyme inhibitors on Alzheimer' s disease
Institution:CHU Quanbing,YUAN Ruimin,TONG Yucui,et al.Department of Neurology,Maanshan Hospital of MCC17,Maanshan 243000,CHINA
Abstract:Objective To observe the effects of hydrochloride captopril,one of angiotensin converting enzyme inhibitors(ACEIs),on behavioral and psychological symptoms and cognitive impairments of Alzheimer′s disease.Methods Fifty-two patients with Alzheimer′s disease were treated with captopril for 12 weeks.The neural psychiatric questionnaire(NPI) and the mini-mental state examination(MMSE) were used to evaluate the efficacy and cognitive changes.Results After treated for 12 weeks,the scores of each NPI factor were significantly decreased(P<0.05) and total scores of NPI decreased by 81.47%(P<0.05).The distress degrees of caregivers of patients decreased while the behavioral and psychological symptoms of patients improved.But the patients showed no cognitive benefits(P>0.05).Conclusion Hydrochloride captopril could significantly reduce the psychological and behavioral symptoms without improvement in the cognitive impairments.
Keywords:Alzheimer′s disease  Angiotensin converting enzyme inhibitors
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号